Nanologica AB engages in the research and development of pharmaceutical products. It offers the NLAB Saga product, which is a silica-based purification media for preparative chromatography. The company was founded by Alfonso Garcia-Bennett on March 25, 2004 and is headquartered in Södertälje, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company